(BRIEF) QIAGEN, a leading provider of molecular diagnostics and life sciences solutions, is particularly expanding its operations in the Middle East region. In early 2024, the company will open its regional headquarters in Riyadh, Saudi Arabia, to its advertising footprint. QIAGEN also signed a Memorandum of Understanding (MoU) with the Saudi Arabian Ministry of Health for infection control and public fitness projects. In addition, QIAGEN, through its partner Taiba Medserv LLC, won a tender for the supply of QuantiFERON-TB Gold Plus tests for Oman’s National Tuberculosis (TB) Screening Program, which aims to test up to 800,000 people over two years. These projects reflect QIAGEN’s commitment to promoting fitness care and addressing critical situations that demand fitness in the Middle East region.
(PRESS RELEASE) VENLO, January 4, 2024 — /EuropaWire/ — QIAGEN (NYSE: QGEN; Frankfurt Prime Standard (QIA) announced an expansion of its operations in the Middle East region, which includes 3 main developments:
“At QIAGEN, we believe that achieving better fitness care outcomes starts with a strong foundation of collaboration and innovation, and we are excited to play a huge role in advancing fitness and wellness across the Middle East. We are proud to contribute to global efforts to end tuberculosis and other serious health threats. Our new regional headquarters in Riyadh will allow us to better serve our consumers and foster strong partnerships with local stakeholders,” said Simona Grandits, Senior Director and Head of EEMEA Sales and Marketing at QIAGEN.
QIAGEN recently signed a Memorandum of Understanding (MoU) with Saudi Arabia’s Ministry of Health that covers various public fitness and infection projects and aligns with Saudi Arabia’s Vision 2030 fitness sector transformation agenda.
The MoU includes:
Screening latent TB infections is critical in efforts to end TB, a disease that kills more than a million people a year. It is estimated that one in four people worldwide suffers from a latent TB infection, and between 5% and 10% of them are estimated. expand active TB at some point.
QIAGEN’s QuantiFERON-TB Gold Plus assay, as it should, detects tuberculosis infection by identifying gamma interferon released by T cells in reaction to tuberculosis-specific antigens. This single-visit screening surpasses the century-old two-visit tuberculosis skin screening (TST). especially for patients from countries with a higher tuberculosis burden who have obtained the BCG vaccine. CDC and WHO support the use of QuantiFERON-TB Gold Plus in all settings to combat the global tuberculosis epidemic.
Media Contact:
IR Contacts
SOURCE: QIAGEN
MORE ON QIAGEN, ETC. :QIAGEN to Host 2023 Global TB Summit: Advancing TB Awareness and ActionQIAGEN Advances NGS Efficacy with QIAseq Standardization Kits for ADNQIAGEN Library Optimizationqiagen and Servier Collaborate to Develop Diagnostic Test for Hard-to-Treat Blood CancerLeading Molecular Products Supplier Sample to Insight Solutions QIAGEN Announces Expansion Supplier Molecular Response Leader Sample to Insight QIAGEN Announces Major Expansion of Its Virtual PCR (dPCR) OfferingsQIAGEN, der führende Anbieter von molekularen Sample-to-Insight-Lösungen, kündigt eine bedeutende Erweiterung seines Angebots and virtualen PCR (dPCR)-Assays anQIAGEN gibt neue Meilensteine für seinen Tuberkulose-Test QuantiFERON bekanntQIAGEN Announces New Milestones for Its Tuberculosis Assay QuantiFERONQIAGEN Announces New Milestones for Its Tuberculosis Assay QuantiFERONQIAGEN announces two new collaborations for its QIAcuity dPCR platform: Atila BioSystems and Actome
EuropaWire (EW) is, in fact, the first pan-European press release distribution and distribution service for Europe and the European Union, which aims to consolidate Europe’s voice on the global stage of news companies. press and media. The press service comes with complex submission forms, flexible PR pricing and budgets, granular targeting, unlimited maximum success across countries, markets, verticals, sectors, audiences, languages, etc. , translation and localization for greater impact locally. Reports, metrics, and insights that aggregate measured PR success, reads, interactions, impact, etc. , with no limits on words, photographs, and multimedia to accompany your post, among others. Your press releases will be among the releases of Europe’s largest and most vital companies, brands and institutions.
HOW DO I GET STARTED?